SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-05-018062
Filing Date
2005-04-26
Accepted
2005-04-26 12:18:19
Documents
14
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a05-1938_210k.htm 10-K 1441427
2 EX-10.38 a05-1938_2ex10d38.htm EX-10.38 141341
3 EX-10.39 a05-1938_2ex10d39.htm EX-10.39 118068
4 EX-10.40 a05-1938_2ex10d40.htm EX-10.40 19623
5 EX-10.41 a05-1938_2ex10d41.htm EX-10.41 20444
6 EX-21.1 a05-1938_2ex21d1.htm EX-21.1 6632
7 EX-23.1 a05-1938_2ex23d1.htm EX-23.1 2272
8 EX-31.1 a05-1938_2ex31d1.htm EX-31.1 8646
9 EX-31.2 a05-1938_2ex31d2.htm EX-31.2 8592
10 EX-32 a05-1938_2ex32.htm EX-32 5552
11 GRAPHIC g19382daimage002.gif GRAPHIC 13929
12 GRAPHIC g19382daimage004.gif GRAPHIC 4174
13 GRAPHIC g19382daimage006.gif GRAPHIC 2410
14 GRAPHIC g19382dcimage002.gif GRAPHIC 4565
  Complete submission text file 0001104659-05-018062.txt   1809264
Mailing Address 135 BEAVER ST WATHAM MA 02452
Business Address 135 BEAVER ST WATHAM MA 02452 1-781-398-0700
INTERLEUKIN GENETICS INC (Filer) CIK: 0001037649 (see all company filings)

IRS No.: 943123681 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-23413 | Film No.: 05772135
SIC: 2835 In Vitro & In Vivo Diagnostic Substances